Latest Posts
About This Stock
More About This Stock
Read
Read
Jefferies Sees 'Attractive Buying Opportunities' In Biotech
Article By:
The Fly
Tuesday, October 18, 2016 10:16 AM EDT
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment.
Alder BioPharmaceuticals Announces Commencement Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Wednesday, April 6, 2016 5:41 PM EDT
Alder BioPharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, announced today that it intends to offer and sell, subject to market and other conditions, $100 million of its common stock in an underwritten public offering.
In this article: ALDR